Neuronetics, Inc.

NasdaqGM:STIM Stock Report

Market Cap: US$42.2m

Neuronetics Management

Management criteria checks 1/4

Neuronetics' CEO is Keith Sullivan, appointed in Jul 2020, has a tenure of 4.42 years. total yearly compensation is $2.99M, comprised of 23.4% salary and 76.6% bonuses, including company stock and options. directly owns 2.44% of the company’s shares, worth $1.03M. The average tenure of the management team and the board of directors is 1.9 years and 4.4 years respectively.

Key information

Keith Sullivan

Chief executive officer

US$3.0m

Total compensation

CEO salary percentage23.4%
CEO tenure4.4yrs
CEO ownership2.4%
Management average tenure1.9yrs
Board average tenure4.4yrs

Recent management updates

Here's Why Shareholders May Want To Be Cautious With Increasing Neuronetics, Inc.'s (NASDAQ:STIM) CEO Pay Packet

May 24
Here's Why Shareholders May Want To Be Cautious With Increasing Neuronetics, Inc.'s (NASDAQ:STIM) CEO Pay Packet

Recent updates

Neuronetics, Inc. (NASDAQ:STIM) Analysts Just Slashed Next Year's Revenue Estimates By 12%

Nov 18
Neuronetics, Inc. (NASDAQ:STIM) Analysts Just Slashed Next Year's Revenue Estimates By 12%

A Piece Of The Puzzle Missing From Neuronetics, Inc.'s (NASDAQ:STIM) 28% Share Price Climb

Nov 05
A Piece Of The Puzzle Missing From Neuronetics, Inc.'s (NASDAQ:STIM) 28% Share Price Climb

Investors Give Neuronetics, Inc. (NASDAQ:STIM) Shares A 60% Hiding

Aug 13
Investors Give Neuronetics, Inc. (NASDAQ:STIM) Shares A 60% Hiding

Here's Why Shareholders May Want To Be Cautious With Increasing Neuronetics, Inc.'s (NASDAQ:STIM) CEO Pay Packet

May 24
Here's Why Shareholders May Want To Be Cautious With Increasing Neuronetics, Inc.'s (NASDAQ:STIM) CEO Pay Packet

The Neuronetics, Inc. (NASDAQ:STIM) First-Quarter Results Are Out And Analysts Have Published New Forecasts

May 09
The Neuronetics, Inc. (NASDAQ:STIM) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Neuronetics: Reality Set In

May 09

Market Cool On Neuronetics, Inc.'s (NASDAQ:STIM) Revenues Pushing Shares 36% Lower

May 08
Market Cool On Neuronetics, Inc.'s (NASDAQ:STIM) Revenues Pushing Shares 36% Lower

Neuronetics (NASDAQ:STIM) Has Debt But No Earnings; Should You Worry?

May 01
Neuronetics (NASDAQ:STIM) Has Debt But No Earnings; Should You Worry?

Even With A 26% Surge, Cautious Investors Are Not Rewarding Neuronetics, Inc.'s (NASDAQ:STIM) Performance Completely

Mar 17
Even With A 26% Surge, Cautious Investors Are Not Rewarding Neuronetics, Inc.'s (NASDAQ:STIM) Performance Completely

Neuronetics: Modest Improvements Are Not Enough

Jan 30

Neuronetics, Inc. (NASDAQ:STIM) Soars 61% But It's A Story Of Risk Vs Reward

Dec 19
Neuronetics, Inc. (NASDAQ:STIM) Soars 61% But It's A Story Of Risk Vs Reward

Neuronetics, Inc.'s (NASDAQ:STIM) Shares Not Telling The Full Story

Jun 21
Neuronetics, Inc.'s (NASDAQ:STIM) Shares Not Telling The Full Story

Does Neuronetics (NASDAQ:STIM) Have A Healthy Balance Sheet?

May 10
Does Neuronetics (NASDAQ:STIM) Have A Healthy Balance Sheet?

Neuronetics: Growth To Capture, But Fairly Priced

Sep 06

Is Neuronetics (NASDAQ:STIM) Using Debt Sensibly?

Sep 06
Is Neuronetics (NASDAQ:STIM) Using Debt Sensibly?

Neuronetics gets FDA nod for its D-Tect accessory product for use to treat depression

Aug 29

Neuronetics GAAP EPS of -$0.39 beats by $0.02, revenue of $16.3M beats by $0.84M , revises FY guidance

Aug 02

Neuronetics stock soars 30% as FDA clears NeuroStar system for anxious depression

Jul 19

Is Neuronetics (NASDAQ:STIM) A Risky Investment?

Jun 08
Is Neuronetics (NASDAQ:STIM) A Risky Investment?

CEO Compensation Analysis

How has Keith Sullivan's remuneration changed compared to Neuronetics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$36m

Jun 30 2024n/an/a

-US$32m

Mar 31 2024n/an/a

-US$28m

Dec 31 2023US$3mUS$700k

-US$30m

Sep 30 2023n/an/a

-US$33m

Jun 30 2023n/an/a

-US$31m

Mar 31 2023n/an/a

-US$37m

Dec 31 2022US$2mUS$676k

-US$37m

Sep 30 2022n/an/a

-US$37m

Jun 30 2022n/an/a

-US$37m

Mar 31 2022n/an/a

-US$34m

Dec 31 2021US$3mUS$650k

-US$31m

Sep 30 2021n/an/a

-US$27m

Jun 30 2021n/an/a

-US$22m

Mar 31 2021n/an/a

-US$23m

Dec 31 2020US$4mUS$280k

-US$27m

Compensation vs Market: Keith's total compensation ($USD2.99M) is above average for companies of similar size in the US market ($USD653.16K).

Compensation vs Earnings: Keith's compensation has increased whilst the company is unprofitable.

CEO

Keith Sullivan (66 yo)

4.4yrs

Tenure

US$2,990,985

Compensation

Mr. Keith J. Sullivan has been President, Chief Executive Officer and Director of Neuronetics, Inc. since July 14, 2020. Mr. Sullivan has been a Director of Venus Concept Inc. (formerly known as Restoratio...

Leadership Team

NamePositionTenureCompensationOwnership
Keith Sullivan
President4.4yrsUS$2.99m2.44%
$ 1.0m
Stephen Furlong
Executive VP5.4yrsUS$1.36m0.85%
$ 357.0k
W. Macan
Executive VP4.9yrsUS$1.16m0.60%
$ 253.4k
Rusty Page
Senior VP of Operations & Quality1.9yrsno datano data
Lisa Metzner-Rosas
Senior VP & Chief Marketing Officer1.6yrsno datano data
Sara Grubbs
Senior VP & Chief Revenue Officer1.8yrsno datano data
Rick Grubbs
Senior Vice President of National Accounts1.8yrsno datano data
Cory Anderson
Senior Vice President of R&D and Clinical1.8yrsno datano data

1.9yrs

Average Tenure

60yo

Average Age

Experienced Management: STIM's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Keith Sullivan
President4.4yrsUS$2.99m2.44%
$ 1.0m
Glenn Muir
Independent Director7.4yrsUS$182.50k0.67%
$ 282.8k
Sheryl Conley
Independent Director5.2yrsUS$175.00k0.26%
$ 109.2k
Robert Cascella
Independent Chairman of the Board3.7yrsUS$245.00k1.06%
$ 447.4k
Megan Rosengarten
Independent Director3.3yrsUS$162.50k0.28%
$ 119.4k

4.4yrs

Average Tenure

65yo

Average Age

Experienced Board: STIM's board of directors are considered experienced (4.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 09:14
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Neuronetics, Inc. is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael GormanBTIG
William PlovanicCanaccord Genuity
David TurkalyJMP Securities